CA
NZ
UK
AU
IND
US
After two consecutive regulatory rejections, Replimune Group (Nasdaq: REPL) has secured an agreement with the U.S. Food and Drug Administration to resubmit itsMarketingapplication for RP1, an oncolytic immunotherapy targeting patients with advanced melanoma who have stopped responding to standard checkpoint inhibitor treatment.
BigBear.ai, Inc. (NYSE: BBAI) climbed 13% on a combination of operational progress and sector euphoria. The defense-technology company posted Q1 2026 results showing meaningful backlog expansion and margin acceleration, but the underlying story remains fragile: the stock's surge owes more to external sector momentum …
Axon Enterprise, Inc. (Nasdaq: AXON) delivered anEarningsperformance sufficiently strong to justify investor relief but not so transformative as to resolve valuation unease. The 12% single-session surge reflects genuine operational momentum colliding with technical recovery from a six-month decline. Separating the two is critical for …
AEVEX Aerospace Corp. (NYSE: AVEX) climbed 31% amid a sector-wide rally in drone and unmanned-systems names. However, this surge represents perhaps the purest expression of sector momentum in today's market: a company that went public less than two months ago, riding tailwinds created by …
AeroVironment, Inc. (Nasdaq: AVAV) climbed 18% amid the broader drone-dominance sector rally triggered by Pentagon equity-stake discussions and Trump's $1.5 trillion FY2027 defense budget proposal. However, the company's operational fundamentalsWarrantanalysis separate from sector narrative. AVAV is not merely a momentum play; the company is …
Ascent Solar Technologies, Inc. (NASDAQ: ASTI), a $74.47 million market-Capitalizationmanufacturer of flexible thin-film copper-indium-gallium-diselenide (CIGS) photovoltaic modules, jumped 16% on concrete progress validating a speculative but strategically coherent thesis: that space-based solar power generation represents a durable commercial opportunity, and that ASTI's CIGS technology …
Shares of Astrotech Corporation (NASDAQ: ASTC) delivered one of the strongest rallies in the U.S. stock market after investors reacted to a combination of regulatory approvals and ambitious long-term strategic initiatives tied to space-resource development.
Shares of Aspire Biopharma Holdings climbed sharply in the latest U.S.Trading sessionas investors assessed a series of financing andCapital-structure announcements tied to the healthcare company’s ongoing strategic plans.
Absci Corporation (Nasdaq: ABSI), an AI-native drug-discovery company leveraging generative design to create antibody therapeutics, delivered meaningful clinical progress in Q1 2026, advancing its lead program ABS-201 beyond safety-cohort dosing into patient populations while simultaneously announcingWall Streetconference participation that will position the company for …
Agilent Technologies (NYSE: A), a leader in life-sciences laboratory instruments, diagnostics systems and detection software, delivered strong operational momentum in Q2 fiscal 2026, prompting institutional investors andEquityanalysts to reassess the company'sEarningstrajectory and secular growth drivers. The stock exploded from a May 27 close near …
Please wait processing your request...